本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Clovis Oncology

0.0812
0.0000
成交量:- -
成交額:- -
市值:1,177.04萬
市盈率:-0.04
高:0.0812
開:0.0812
低:0.0812
收:0.0812
52周最高:3.32
52周最低:0.0760
股本:1.45億
流通股本:1.43億
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.8161
每股收益(LYR):-2.2897
淨資產收益率:193.18%
總資產收益率:-30.18%
市淨率:-0.03
市盈率(LYR):-0.04

資料載入中...

2019/12/02

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/15

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/08

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/11/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/07

重要事件披露

Current report, items 2.02 and 9.01
2019/09/27

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/08/23

重要事件披露

Current report, items 2.03, 3.02, 8.01, and 9.01
2019/08/20

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/19

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/19

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/19

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/16

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/16

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/15

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/13

重要事件披露

Current report, items 1.01, 2.03, 3.02, 8.01, and 9.01
2019/08/02

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/08/01

重要事件披露

Current report, items 2.02 and 9.01
2019/07/31

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals